Alger Health is trading at 13.70 as of the 1st of December 2024; that is 0.37 percent increase since the beginning of the trading day. The fund's open price was 13.65. Alger Health has about a 22 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Alger Health Sciences are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of November 2024 and ending today, the 1st of December 2024. Click here to learn more.
The fund invests at least 80 percent of its net assets, plus any borrowings for investment purposes, in equity securities of companies of any market capitalization that are engaged in the health sciences sector. It can invest in foreign securities. More on Alger Health Sciences
Alger Health Sciences [AHSCX] is traded in USA and was established 1st of December 2024. Alger Health is listed under Alger category by Fama And French industry classification. The fund is listed under Health category and is part of Alger family. The entity is thematically classified as Healthcare Funds. This fund presently has accumulated 146.94 M in assets under management (AUM) with no minimum investment requirementsAlger Health Sciences is currently producing year-to-date (YTD) return of 5.67%, while the total return for the last 3 years was -7.77%.
Check Alger Health Probability Of Bankruptcy
Instrument Allocation
Top Alger Health Sciences Mutual Fund Constituents
Other Information on Investing in Alger Mutual Fund
Alger Health financial ratios help investors to determine whether Alger Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Alger with respect to the benefits of owning Alger Health security.